• Join
  • Login
  • Contact

Search abstracts

Aligning and constructing dialogue between industry, regulators and payers.

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Presentation
  • By: MARTINS, Ana Paula (Merck, Porto Salvo, Portugal)
  • Abstract:

    New drugs had demonstrating a significant impact in health outcomes. This impact has led to longevity as well as increase of productivity in modern societies. The measurement of both added therapeutic value (risk-benefit compared to alternative therapies) and cost-benefit of new therapies have been requested in the Health Systems to decide whether


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses